Collegeville, PA, United States of America

Clark A Sehon

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

San Diego, CA (US) (2003 - 2005)
King of Prussia, PA (US) (2008 - 2013)
Collegeville, PA (US) (2013 - 2022)

Company Filing History:

6 out of 230

Glaxosmithkline Intellectual Property Development Limited

Ortho-mcneil Pharmaceutical Corp.

patents

4. 1 out of 2,198

Smithkline Beecham Corporation

Years Active: 2003-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11485710 - Heterocyclic amides as kinase inhibitors (2022-11-01),

2. 10940154 - Heterocyclic amides as kinase inhibitors (2021-03-09),

3. 10933070 - Heterocyclic amides as kinase inhibitors (2021-03-02),

4. 10899716 - Heterocyclic amides as kinase inhibitors (2021-01-26),

5. 10590085 - Heterocyclic amides as kinase inhibitors (2020-03-17),

6. 10292987 - Heterocyclic amides as kinase inhibitors (2019-05-21),

7. 8563722 - Stereoselective hydrogenation of a ketone (2013-10-22),

8. 8431590 - Spiroindolines as modulators of chemokine receptors (2013-04-30),

9. 7749998 - Morpholinyl and pyrrolidinyl analogs (2010-07-06),

10. 7723350 - Spiroindolines as modulators of chemokine receptors (2010-05-25),

11. 7432258 - Morpholinyl and pyrrolidinyl analogs (2008-10-07),

12. 6953793 - Substituted pyrazoles (2005-10-11),

13. 6583155 - Method for treating allergies using substituted pyrazoles (2003-06-24),

Title: Clark A Sehon: Innovator in Kinase Inhibitors

Introduction

Clark A Sehon is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 13 patents to his name, Sehon's work has had a considerable impact on pharmaceutical research and development.

Latest Patents

One of his latest patents includes the development of heterocyclic amides as kinase inhibitors. This patent discloses compounds that have the potential to be used in therapeutic applications, showcasing Sehon's innovative approach to drug design.

Career Highlights

Throughout his career, Clark A Sehon has worked with prominent companies such as GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Sehon has collaborated with several talented individuals in his field, including Jae U Jeong and Deepak Bandyopadhyay. These partnerships have further enhanced his research and development efforts.

Conclusion

Clark A Sehon is a distinguished inventor whose work in kinase inhibitors has advanced the field of medicinal chemistry. His contributions continue to influence pharmaceutical research and development, making him a key figure in the industry.

This text is generated by artificial intelligence and may not be accurate.